Cytotoxic Analysis Methods in Bee Products

Ahlquist, D. A. (2010). Molecular detection of colorectal neoplasia. Gastroenterology, 138(6), 2127-2139.

Ahn, M. R., Kumazawa, S., Usui, Y., Nakamura, J., Matsuka, M., Zhu, F., & Nakayama, T. (2007). Antioxidant activity and constituents of propolis collected in various areas of China. Food Chemistry, 101(4), 1383-1392.

Arıkan, S., Cacina, C., Guler, E., Çulcu, S., Tuna, G., & Yaylım-Eraltan, İ. (2012). The effects of NOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population. Molecular biology reports, 39, 3245-3249.

Artale, S., Sartore Bianchi, A., Veronese, S. M., Gambi, V., Sarnataro, C. S., Gambacorta, M., ... & Siena, S. (2008). Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer. Journal of Clinical Oncology, 26(25), 4217-4219.

Baudhuin, L. M., Burgart, L. J., Leontovich, O., & Thibodeau, S. N. (2005). Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome. Familial cancer, 4, 255-265.

Benkovic, V., Knezevic, A. H., Brozovic, G., Knezevic, F., Đikic, D., Bevanda, M., ... & Orsolic, N. (2007). Enhanced antitumor activity of irinotecan combined with propolis and its polyphenolic compounds on Ehrlich ascites tumor in mice. Biomedicine & pharmacotherapy, 61(5), 292-297.

Bertagnolli, M. M., Redston, M., Compton, C. C., Niedzwiecki, D., Mayer, R. J., Goldberg, R. M., ... & Warren, R. S. (2011). Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer—a study of CALGB 9581 and 89803. Journal of clinical oncology, 29(23), 3153.

Boulay, J. L., Mild, G., Lowy, A., Reuter, J., Lagrange, M., Terracciano, L., ... & Rochlitz, C. (2002). SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. British journal of cancer, 87(6), 630-634.

Cacina, C., Yaylim-Eraltan, I., Arikan, S., Saglam, E. K., Zeybek, U., & Isbir, T. (2010). Association between CDKN1A Ser31Arg and C20T gene polymorphisms and colorectal cancer risk and prognosis. in vivo, 24(2), 179-183.

Canbay, E., & Buğra, D. (2011). Kolorektal kanser: Genetik ve moleküler biyoloji araştırmaları hasta tedavisine yeterince yansıyor mu?. Turkish Journal of Surgery, 27(4), 198-205.

Canbay, E., Cakmakoglu, B., Zeybek, U., Sozen, S., Cacina, C., Gulluoglu, M., ... & Bugra, D. (2011). Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population. Current medical research and opinion, 27(7), 1295-1302.

Carvalho, A. A., Finger, D., Machado, C. S., Schmidt, E. M., da Costa, P. M., Alves, A. P. N. N., ... & Torres, Y. R. (2011). In vivo antitumoural activity and composition of an oil extract of Brazilian propolis. Food Chemistry, 126(3), 1239-1245.

Chittenden, T. W., Howe, E. A., Culhane, A. C., Sultana, R., Taylor, J. M., Holmes, C., & Quackenbush, J. (2008). Functional classification analysis of somatically mutated genes in human breast and colorectal cancers. Genomics, 91(6), 508-511.

Cuevas, A., Saavedra, N., Rudnicki, M., Abdalla, D. S., & Salazar, L. A. (2015). ERK1/2 and HIF1α are involved in antiangiogenic effect of polyphenols-enriched fraction from Chilean propolis. Evidence-Based Complementary and Alternative Medicine, 2015.

Danielsen, S. A., Lind, G. E., Bjørnslett, M., Meling, G. I., Rognum, T. O., Heim, S., & Lothe, R. A. (2008). Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instability‐and TP53 mutation‐status. Human mutation, 29(11), E252-E262.

de Groot, A. C. (2013). Propolis: a review of properties, applications, chemical composition, contact allergy, and other adverse effects. Dermatitis, 24(6), 263-282.

Downward, J. (2003). Targeting RAS signalling pathways in cancer therapy. Nature reviews cancer, 3(1), 11-22.

Dundar, M., Caglayan, A. O., Saatci, C., Karaca, H., Baskol, M., Tahiri, S., & Ozkul, Y. (2007). How the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population. Cancer genetics and cytogenetics, 177(2), 95-97.

Fuchs, C., Ogino, S., Meyerhardt, J. A., Irahara, N., Niedzwiecki, D., Hollis, D., ... & Bertagnolli, M. M. (2009). KRAS mutation, cancer recurrence, and patient survival in stage III colon cancer: findings from CALGB 89803. Journal of Clinical Oncology, 27(15_suppl), 4037-4037.

Galati, G., Teng, S., Moridani, M. Y., Chan, T. S., & O'Brien, P. J. (2000). Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics. Drug metabolism and drug interactions, 17(1-4), 311-350.

Grady, W. M., Myeroff, L. L., Swinler, S. E., Rajput, A., Thiagalingam, S., Lutterbaugh, J. D., ... & Markowitz, S. (1999). Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers. Cancer research, 59(2), 320-324.

Grady, W. M., Rajput, A., Myeroff, L., Liu, D. F., Kwon, K., Willis, J., & Markowitz, S. (1998). Mutation of the type II transforming growth factor-β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer research, 58(14), 3101-3104.

Itzkowitz, S. H., Jandorf, L., Brand, R., Rabeneck, L., Schroy III, P. C., Sontag, S., ... & Shuber, A. (2007). Improved fecal DNA test for colorectal cancer screening. Clinical Gastroenterology and Hepatology, 5(1), 111-117.

Itzkowitz, S., Brand, R., Jandorf, L., Durkee, K., Millholland, J., Rabeneck, L., ... & Berger, B. M. (2008). A simplified, noninvasive stool DNA test for colorectal cancer detection. Official journal of the American College of Gastroenterology| ACG, 103(11), 2862-2870.

Kumazawa, S., Hamasaka, T., & Nakayama, T. (2004). Antioxidant activity of propolis of various geographic origins. Food chemistry, 84(3), 329-339.